Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Basel Medical Group Ltd Ordinary Shares (BMGL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: BMGL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.91 - 7.18 | Updated Date 05/15/2025 |
52 Weeks Range 0.91 - 7.18 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Basel Medical Group Ltd Ordinary Shares
Company Overview
History and Background
Basel Medical Group Ltd Ordinary Shares is not a publicly traded US company. It appears to be a Swiss company. Without more context, its history and background cannot be determined.
Core Business Areas
Leadership and Structure
Information on Basel Medical Group Ltd Ordinary Shares is not readily available to describe their leadership team and organizational structure.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
Without knowing the specific area of 'medical' the company is involved in, providing an industry overview is difficult.
Positioning
Without knowing the specific area of 'medical' the company is involved in, explaining its positioning is impossible.
Total Addressable Market (TAM)
TAM data cannot be provided without specifying the company's industry segment.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Insufficient information is available to evaluate the competitive landscape.
Growth Trajectory and Initiatives
Historical Growth: Insufficient information is available to determine historical growth trends.
Future Projections: Insufficient information is available to provide future growth projections.
Recent Initiatives: Insufficient information is available to highlight recent strategic initiatives.
Summary
Due to the lack of readily available information on Basel Medical Group Ltd Ordinary Shares, a complete and accurate analysis is not possible. More company-specific details would be necessary to assess its financial health, competitive position, and future prospects. This information deficit prevents a meaningful determination of the company's strengths, weaknesses, opportunities, and threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Publicly available web searches, information is not readily available
Disclaimers:
The analysis is based on limited available information. The lack of detailed information may render the analysis inaccurate. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Basel Medical Group Ltd Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-02-25 | Group Chief Health Officer & Interim CEO Dr. Yen Feng Chhoa M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 32 | Website https://baselmedical.com |
Full time employees 32 | Website https://baselmedical.com | ||
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services. The company was incorporated in 2023 and is headquartered in Singapore.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.